Skip to content
healthcare.dev

Real Relief

NDC 65808-318, Allium cepa, Aralia racemosa, Arsenicum album, Cuprum metallicum, Euphrasia officinalis, Nux vomica, Sabadilla, Sticta pulmonaria, tablet, from GMP Laboratories of America, Inc..

Product NDC
65808-318
Status
Listed
Labeler
GMP Laboratories of America, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65808-318 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONION8 [hp_X]/1
  • ARALIA RACEMOSA ROOT8 [hp_X]/1
  • ARSENIC TRIOXIDE8 [hp_X]/1
  • COPPER8 [hp_X]/1
  • EUPHRASIA STRICTA8 [hp_X]/1
  • STRYCHNOS NUX-VOMICA SEED8 [hp_X]/1
  • SCHOENOCAULON OFFICINALE SEED8 [hp_X]/1
  • LOBARIA PULMONARIA8 [hp_X]/1

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Inhibit Ovum Fertilization [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]; Vegetable Proteins [CS]

Package NDCNDC-11Package
65808-318-01658080318011 BOTTLE in 1 CARTON (65808-318-01) / 90 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 65808-318 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65808-318 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65808-318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.